Free Trial

Confluent's (CFLT) Equal Weight Rating Reiterated at Morgan Stanley

Confluent logo with Business Services background

Confluent (NASDAQ:CFLT - Get Free Report)'s stock had its "equal weight" rating reissued by stock analysts at Morgan Stanley in a research report issued to clients and investors on Thursday, MarketBeat reports. They presently have a $30.00 target price on the stock, down from their previous target price of $33.00. Morgan Stanley's target price would indicate a potential upside of 10.56% from the stock's previous close.

Other research analysts have also recently issued research reports about the company. TD Cowen lifted their target price on Confluent from $27.00 to $31.00 and gave the company a "buy" rating in a research report on Thursday, October 31st. Piper Sandler lifted their price objective on shares of Confluent from $32.00 to $35.00 and gave the stock an "overweight" rating in a report on Monday, January 6th. Royal Bank of Canada upped their target price on shares of Confluent from $33.00 to $36.00 and gave the stock an "outperform" rating in a research note on Friday, January 3rd. UBS Group increased their target price on shares of Confluent from $23.00 to $26.00 and gave the company a "neutral" rating in a report on Thursday, October 31st. Finally, JPMorgan Chase & Co. boosted their price target on shares of Confluent from $35.00 to $38.00 and gave the stock an "overweight" rating in a report on Wednesday, December 11th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating, nineteen have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $32.37.

Check Out Our Latest Report on Confluent

Confluent Stock Down 2.4 %

Shares of Confluent stock traded down $0.68 during trading hours on Thursday, reaching $27.14. The company's stock had a trading volume of 5,428,621 shares, compared to its average volume of 2,850,846. The company has a market capitalization of $8.90 billion, a P/E ratio of -24.42 and a beta of 0.91. The stock's fifty day simple moving average is $29.64 and its two-hundred day simple moving average is $24.96. Confluent has a one year low of $17.79 and a one year high of $35.07. The company has a debt-to-equity ratio of 1.17, a quick ratio of 4.24 and a current ratio of 4.24.

Confluent (NASDAQ:CFLT - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported ($0.21) earnings per share for the quarter, beating the consensus estimate of ($0.24) by $0.03. The business had revenue of $250.20 million for the quarter, compared to analysts' expectations of $243.98 million. Confluent had a negative net margin of 38.35% and a negative return on equity of 34.05%. On average, research analysts forecast that Confluent will post -0.9 earnings per share for the current year.

Insider Transactions at Confluent

In other news, Director Matthew Craig Miller sold 53,512 shares of Confluent stock in a transaction on Friday, December 6th. The stock was sold at an average price of $33.64, for a total value of $1,800,143.68. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Kong Phan sold 2,096 shares of the business's stock in a transaction on Wednesday, November 20th. The shares were sold at an average price of $28.23, for a total value of $59,170.08. Following the sale, the chief accounting officer now owns 190,680 shares in the company, valued at approximately $5,382,896.40. The trade was a 1.09 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 4,584,712 shares of company stock worth $132,928,936 over the last quarter. Corporate insiders own 13.82% of the company's stock.

Hedge Funds Weigh In On Confluent

A number of large investors have recently modified their holdings of the company. Champlain Investment Partners LLC increased its holdings in Confluent by 72.2% during the 3rd quarter. Champlain Investment Partners LLC now owns 10,700,846 shares of the company's stock worth $218,083,000 after acquiring an additional 4,486,841 shares during the period. 1832 Asset Management L.P. increased its holdings in shares of Confluent by 28.4% in the second quarter. 1832 Asset Management L.P. now owns 7,617,100 shares of the company's stock worth $224,933,000 after purchasing an additional 1,684,100 shares during the period. Fiera Capital Corp purchased a new stake in shares of Confluent in the third quarter worth $21,127,000. Jacobs Levy Equity Management Inc. boosted its stake in Confluent by 46.9% during the third quarter. Jacobs Levy Equity Management Inc. now owns 2,513,426 shares of the company's stock valued at $51,224,000 after buying an additional 802,353 shares during the period. Finally, Oddo BHF Asset Management Sas bought a new stake in Confluent during the third quarter valued at $7,646,000. 78.09% of the stock is currently owned by institutional investors.

Confluent Company Profile

(Get Free Report)

Confluent, Inc operates a data streaming platform in the United States and internationally. The company provides platforms that allow customers to connect their applications, systems, and data layers, such as Confluent Cloud, a managed cloud-native software-as-a-service; and Confluent Platform, an enterprise-grade self-managed software.

Recommended Stories

Analyst Recommendations for Confluent (NASDAQ:CFLT)

Should You Invest $1,000 in Confluent Right Now?

Before you consider Confluent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Confluent wasn't on the list.

While Confluent currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025
Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines